These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15633446)

  • 1. Aspergillus left ventricular assist device endocarditis.
    Barbone A; Pini D; Grossi P; Bandera A; Manasse E; Citterio E; Eusebio A; Silvaggio G; Settepani F; Municinò A; Colombo P; Casari E; Ornaghi D; Gronda E; Gallotti R
    Ital Heart J; 2004 Nov; 5(11):876-80. PubMed ID: 15633446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular assist device-related infection: treatment and outcome.
    Simon D; Fischer S; Grossman A; Downer C; Hota B; Heroux A; Trenholme G
    Clin Infect Dis; 2005 Apr; 40(8):1108-15. PubMed ID: 15791509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular assist device placement in a patient with end-stage heart failure and human immunodeficiency virus.
    Fieno DS; Czer LS; Schwarz ER; Simsir S
    Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):919-20. PubMed ID: 19706718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients.
    Feller ED; Sorensen EN; Haddad M; Pierson RN; Johnson FL; Brown JM; Griffith BP
    Ann Thorac Surg; 2007 Mar; 83(3):1082-8. PubMed ID: 17307463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
    Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
    J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable left ventricular assist devices: new hope for patients with end-stage heart failure.
    Milano CA; Lodge AJ; Blue LJ; Smith PK; Felker GM; Hernandez AF; Rosenberg PB; Rogers JG
    N C Med J; 2006; 67(2):110-5. PubMed ID: 16752713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fungemia associated with left ventricular assist device support.
    Bagdasarian NG; Malani AN; Pagani FD; Malani PN
    J Card Surg; 2009; 24(6):763-5. PubMed ID: 20078725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and clinical management of life-threatening left ventricular assist device failure.
    Birks EJ; Tansley PD; Yacoub MH; Bowles CT; Hipkin M; Hardy J; Banner NR; Khaghani A
    J Heart Lung Transplant; 2004 Aug; 23(8):964-9. PubMed ID: 15312826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure.
    Dang NC; Topkara VK; Mercando M; Kay J; Kruger KH; Aboodi MS; Oz MC; Naka Y
    J Heart Lung Transplant; 2006 Jan; 25(1):1-6. PubMed ID: 16399523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy.
    Esmore D; Kaye D; Spratt P; Larbalestier R; Ruygrok P; Tsui S; Meyers D; Fiane AE; Woodard J
    J Heart Lung Transplant; 2008 Jun; 27(6):579-88. PubMed ID: 18503955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Miller LW; Deng M; Naka Y; Mancini D
    Circ Heart Fail; 2009 Jan; 2(1):3-10. PubMed ID: 19808309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective study of left ventricular assist device-related infections.
    Bentz B; Hupcey JE; Polomano RC; Boehmer JP
    J Cardiovasc Manag; 2004; 15(1):9-16. PubMed ID: 14976692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fungal infections in left ventricular assist device recipients. Incidence, prophylaxis, and treatment.
    Goldstein DJ; el-Amir NG; Ashton RC; Catanese K; Rose RA; Levin HR; Oz MC
    ASAIO J; 1995; 41(4):873-5. PubMed ID: 8589469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe.
    Pae WE; Connell JM; Adelowo A; Boehmer JP; Korfer R; El-Banayosy A; Hetzer R; Vigano M; Pavie A;
    J Heart Lung Transplant; 2007 Mar; 26(3):219-29. PubMed ID: 17346623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial.
    Dembitsky WP; Tector AJ; Park S; Moskowitz AJ; Gelijns AC; Ronan NS; Piccione W; Holman WL; Furukawa S; Weinberg AD; Heatley G; Poirier VL; Damme L; Long JW
    Ann Thorac Surg; 2004 Dec; 78(6):2123-9; discussion 2129-30. PubMed ID: 15561049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
    Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
    J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of recurrent heart failure associated with left ventricular assist device dysfunction.
    Jaski BE; Miller DA; Hoagland PM; Gordon JB; Chillcott SR; Stahovich MJ; Adamson RM; Baradarian S; Dembitsky WP
    J Heart Lung Transplant; 2005 Dec; 24(12):2060-7. PubMed ID: 16364850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.